The first articles published in Journal of Angiogenesis Research
today cover a wide range of angiogenesis related topics, reflecting the
journal’s aim of providing a pivotal platform for researchers in this area. Dr Meadows and colleagues examine the role of Akt signalling factors in
early embryonic heart development, while Professor Mross and colleagues
assess the cancer drug
vandetanib on tumor vasculature in colorectal and liver cancer patients,
and Professor Ribatti provides an overview on the role of William Harvey in
the circulation of blood.

Angiogenesis, the growth of new blood vessels, is a key
process occurring in the progression of diseases such as cancer, diabetic retinopathies, age-related
macular degeneration and atherosclerosis. The rapid dissemination and
implementation of advances in the field of angiogenesis will impact
significantly on the understanding and treatment of these diseases. “For these reasons and due to the
continual expansion of this area of biomedical research, we are proud to announce the launch of Journal
of Angiogenesis Research.” say Editors-in-Chief, Mark
Slevin, Yihai Cao and Jan Kitajewski.

If you are interested in this area of research, please visit the journal homepage and if you would like to receive regular emails detailing
the most recently published articles then please sign up for article alerts.